Phase 2 Asthma Clinical Trials

43 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 120 of 43 trials

Recruiting
Phase 2

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Eosinophilic Asthma
Kymera Therapeutics, Inc.264 enrolled9 locationsNCT07323654
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Moderate to Severe Asthma
Incyte Corporation240 enrolled84 locationsNCT05851443
Recruiting
Phase 1Phase 2

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

Allergic AsthmaAllergic Rhinitis
University of Zurich36 enrolled1 locationNCT06960382
Recruiting
Phase 2

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Asthma
Eli Lilly and Company531 enrolled121 locationsNCT07219173
Recruiting
Phase 2

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

Asthma
Enveda Therapeutics50 enrolled11 locationsNCT07301255
Recruiting
Phase 2

Dupilumab Effects Against Aeroallergen Challenge

Asthma, Allergic
The University of Texas Health Science Center at San Antonio88 enrolled2 locationsNCT05720325
Recruiting
Phase 2

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Asthma
Vanderbilt University Medical Center100 enrolled1 locationNCT05254314
Recruiting
Phase 2

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Asthma
AstraZeneca540 enrolled208 locationsNCT06932263
Recruiting
Phase 2

A Clinical Trial of Soluble Fiber for Asthma

Asthma in Children
Phoenix Children's Hospital105 enrolled1 locationNCT06372249
Recruiting
Phase 2

5HTP Regulation Of Asthma In Children

Mild or Moderate Asthma With Allergic Sensitization
Indiana University20 enrolled1 locationNCT04160910
Recruiting
Phase 2

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

AsthmaCystic Fibrosis
The Hospital for Sick Children30 enrolled1 locationNCT02740868
Recruiting
Phase 2

A Study to Evaluate Solriktug in Adult Participants With Asthma

Asthma
Uniquity One (UNI)140 enrolled74 locationsNCT06496607
Recruiting
Phase 2

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

Asthma (Diagnosis)
Windward Bio136 enrolled64 locationsNCT07120503
Recruiting
Phase 2

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

Severe Asthma
Upstream Bio Inc.436 enrolled84 locationsNCT06966479
Recruiting
Phase 2

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Asthma
Novartis Pharmaceuticals42 enrolled23 locationsNCT05222529
Recruiting
Phase 2

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Asthma
Pfizer252 enrolled125 locationsNCT06977581
Recruiting
Phase 2

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

Asthma Acute
Connect Biopharm LLC160 enrolled46 locationsNCT06940141
Recruiting
Phase 2

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Asthma
Sanofi1,147 enrolled240 locationsNCT06676319
Recruiting
Phase 2

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma.

Asthma
Sanofi900 enrolled114 locationsNCT06609239
Recruiting
Phase 2

Escitalopram in Asthma Patients With Frequent Exacerbation

Asthma
University of Texas Southwestern Medical Center105 enrolled1 locationNCT06216535